According to our established customers, due to the insufficient support from their suppliers, they sometimes find it hard to compete against their competitors. According to our investigation, more than 70% of experiment failures contributed by operation errors in labs; a delayed technical support and insufficient technical guidance will not only lead to credit crisis, but sales loss. Sansure strives to provide the best technical support and training to all our partners with final goal to serve the end users well. Sansure is young and vigorous company; and we have a better recognition of what fully support to our partners means to us.

This April 18, two guests from OMC Company in Bangladesh were invited to China for a seven-day technical, marketing and full automation training. We arranged two technical specialists with fully day availability to ensure their best training; meanwhile, a driver and a sales representative were also in company to ensure their carefree accommodation and visit tour. Seven days past, both of them learned a lot preparing for the following massive marketing and they also indeed enjoyed the stay with us. 

OMC is our authorized partner in Bangladesh dealing with ABI, Invitrogene and Beckman Coulter exclusively in the country. Sansure's kits have been an excellent combination to ABI PCR machines. With our best support, they achieved a USD50,000 sales volume for Sansure IVD real time PCR assay in less than five months.In order to fulfill our commitment/support to partners, we scheduled a free training to them by providing free round trip flight tickets, free accommodation, and all the reasonable cost in order to ensure their comfortable stay and sufficient training. Most importantly, they are full trained in our facility for the coming massive marketing.

According to our end users, we Sansure are not only featured with Roche level qualified products, which we believe, is less than enough to compete with Roche. We try to provide the best support and services to out partners and end users. We believe this is the only way to compete against Roche; and we are actually on the way consuming market share from Roche, Abbott and Qiagen.